v3.26.1
Summary of Significant Accounting Policies - Schedule of Unaudited Condensed Consolidated Statement of Operations Restated (Details) - USD ($)
 3 Months Ended 9 Months Ended
Dec. 31, 2025
Sep. 30, 2025
Jun. 30, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Dec. 31, 2025
Dec. 31, 2024
Schedule of Unaudited Condensed Consolidated Statement of Operations Restated [Line Items]                
Change in fair value of derivative liabilities $ 813,405     $ 121,314     $ 893,714 $ 105,900
Excess of warrant fair value over offering proceeds 2,896,455         2,896,455
Other income, net 230,697     32,232     292,493 65,737
Total other (expense) income, net (1,852,353)     153,546     (1,710,248) 171,637
Loss before income tax expense (2,948,938)     (257,495)     (3,867,047) (992,186)
Net Loss from continuing operations (2,948,938)     (257,495)     (3,867,047) (992,186)
Net loss (2,969,482) $ (723,730) $ (276,438) (583,378) $ (425,453) $ (762,818) (3,969,650) (1,771,649)
Net loss attributable to the Company’s stockholders (3,133,034)     (565,315)     (3,946,174) (1,950,184)
Comprehensive loss (3,140,575)     (722,035)     (4,157,675) (1,823,519)
Total comprehensive loss attributable to stockholders $ (3,155,591)     $ (707,313)     $ (3,985,382) $ (2,061,446)
Loss per share - basic (in Dollars per share) [1] $ (0.88)     $ (0.54)     $ (1.92) $ (1.85)
Loss per share - diluted (in Dollars per share) [1] (0.88)     (0.54)     (1.92) (1.85)
Loss per share from continuing operation Basic (in Dollars per share) (0.87)     (0.23)     (1.87) (1.11)
Loss per share from continuing operation Diluted (in Dollars per share) $ (0.87)     $ (0.23)     $ (1.87) $ (1.11)
Adjustments [Member]                
Schedule of Unaudited Condensed Consolidated Statement of Operations Restated [Line Items]                
Change in fair value of derivative liabilities $ 813,225           $ 813,225  
Excess of warrant fair value over offering proceeds (2,896,455)           (2,896,455)  
Other income, net (12,575)           (12,575)  
Total other (expense) income, net (2,095,805)           (2,095,805)  
Loss before income tax expense (2,095,805)           (2,095,805)  
Net Loss from continuing operations (2,095,805)           (2,095,805)  
Net loss (2,095,805)           (2,095,805)  
Net loss attributable to the Company’s stockholders (2,095,805)           (2,095,805)  
Comprehensive loss (2,095,805)           (2,095,805)  
Total comprehensive loss attributable to stockholders $ (2,095,805)           $ (2,095,805)  
Loss per share - basic (in Dollars per share) [2] $ (0.59)           $ (1.02)  
Loss per share - diluted (in Dollars per share) [2] (0.59)           (1.02)  
Loss per share from continuing operation Basic (in Dollars per share) (0.59)           (1.02)  
Loss per share from continuing operation Diluted (in Dollars per share) $ (0.59)           $ (1.02)  
Reported [Member]                
Schedule of Unaudited Condensed Consolidated Statement of Operations Restated [Line Items]                
Change in fair value of derivative liabilities $ 180           $ 80,489  
Excess of warrant fair value over offering proceeds            
Other income, net 243,272           305,068  
Total other (expense) income, net 243,452           385,557  
Loss before income tax expense (853,133)           (1,771,242)  
Net Loss from continuing operations (853,133)           (1,771,242)  
Net loss (873,677)           (1,873,845)  
Net loss attributable to the Company’s stockholders (1,037,229)           (1,850,369)  
Comprehensive loss (1,044,770)           (2,061,870)  
Total comprehensive loss attributable to stockholders $ (1,059,786)           $ (1,889,577)  
Loss per share - basic (in Dollars per share) [2] $ (0.29)           $ (0.9)  
Loss per share - diluted (in Dollars per share) [2] (0.29)           (0.9)  
Loss per share from continuing operation Basic (in Dollars per share) (0.28)           (0.85)  
Loss per share from continuing operation Diluted (in Dollars per share) $ (0.28)           $ (0.85)  
Restated [Member]                
Schedule of Unaudited Condensed Consolidated Statement of Operations Restated [Line Items]                
Change in fair value of derivative liabilities $ 813,405           $ 893,714  
Excess of warrant fair value over offering proceeds (2,896,455)           (2,896,455)  
Other income, net 230,697           292,493  
Total other (expense) income, net (1,852,353)           (1,710,248)  
Loss before income tax expense (2,948,938)           (3,867,047)  
Net Loss from continuing operations (2,948,938)           (3,867,047)  
Net loss (2,969,482)           (3,969,650)  
Net loss attributable to the Company’s stockholders (3,133,034)           (3,946,174)  
Comprehensive loss (3,140,575)           (4,157,675)  
Total comprehensive loss attributable to stockholders $ (3,155,591)           $ (3,985,382)  
Loss per share - basic (in Dollars per share) [2] $ (0.88)           $ (1.92)  
Loss per share - diluted (in Dollars per share) [2] (0.88)           (1.92)  
Loss per share from continuing operation Basic (in Dollars per share) (0.87)           (1.87)  
Loss per share from continuing operation Diluted (in Dollars per share) $ (0.87)           $ (1.87)  
[1] Giving retroactive effect to the 1-for-10 reverse stock split effected on July 29, 2025
[2] Giving retroactive effect to the 1-for-10 reverse stock split effected on July 29, 2025